Cargando…
Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity
AIM: Ebselen (Eb) is an example of a repurposed drug with poor aqueous solubility which requires sophisticated delivery system such as nanoencapsulation in nanocapsules for topical application. MATERIALS & METHODS: Eb-nanocapsules were examined for morphology, activity against Candida spp., cyto...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334256/ https://www.ncbi.nlm.nih.gov/pubmed/29873597 http://dx.doi.org/10.2217/nnm-2017-0337 |
_version_ | 1785070821808537600 |
---|---|
author | Jaromin, Anna Zarnowski, Robert Piętka-Ottlik, Magdalena Andes, David R Gubernator, Jerzy |
author_facet | Jaromin, Anna Zarnowski, Robert Piętka-Ottlik, Magdalena Andes, David R Gubernator, Jerzy |
author_sort | Jaromin, Anna |
collection | PubMed |
description | AIM: Ebselen (Eb) is an example of a repurposed drug with poor aqueous solubility which requires sophisticated delivery system such as nanoencapsulation in nanocapsules for topical application. MATERIALS & METHODS: Eb-nanocapsules were examined for morphology, activity against Candida spp., cytotoxicity and skin permeation. RESULTS: Eb-nanocapsules were active against skin-infecting Candida tropicalis, Candida albicans and Candida parapsilosis yeasts (minimal inhibitory concentration values were about 4-, 2- and 1.25-times lower vs free Eb, respectively) and able to suppress induced lipid oxidation in the oil/water emulsion. Moreover, demonstrated minimal toxicity in normal human dermal fibroblast cell line, whereas ex vivo skin permeation studies showed no transdermal passage and strong interactions with stratum corneum. CONCLUSION: Eb-nanocapsules represent a promising, safe and complementary alternative to the treatment of cutaneous candidiasis. |
format | Online Article Text |
id | pubmed-10334256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-103342562023-07-12 Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity Jaromin, Anna Zarnowski, Robert Piętka-Ottlik, Magdalena Andes, David R Gubernator, Jerzy Nanomedicine (Lond) Research Article AIM: Ebselen (Eb) is an example of a repurposed drug with poor aqueous solubility which requires sophisticated delivery system such as nanoencapsulation in nanocapsules for topical application. MATERIALS & METHODS: Eb-nanocapsules were examined for morphology, activity against Candida spp., cytotoxicity and skin permeation. RESULTS: Eb-nanocapsules were active against skin-infecting Candida tropicalis, Candida albicans and Candida parapsilosis yeasts (minimal inhibitory concentration values were about 4-, 2- and 1.25-times lower vs free Eb, respectively) and able to suppress induced lipid oxidation in the oil/water emulsion. Moreover, demonstrated minimal toxicity in normal human dermal fibroblast cell line, whereas ex vivo skin permeation studies showed no transdermal passage and strong interactions with stratum corneum. CONCLUSION: Eb-nanocapsules represent a promising, safe and complementary alternative to the treatment of cutaneous candidiasis. Future Medicine Ltd 2018-06-06 2018-05 /pmc/articles/PMC10334256/ /pubmed/29873597 http://dx.doi.org/10.2217/nnm-2017-0337 Text en © 2018 Anna Jaromin https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Research Article Jaromin, Anna Zarnowski, Robert Piętka-Ottlik, Magdalena Andes, David R Gubernator, Jerzy Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity |
title | Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity |
title_full | Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity |
title_fullStr | Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity |
title_full_unstemmed | Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity |
title_short | Topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity |
title_sort | topical delivery of ebselen encapsulated in biopolymeric nanocapsules: drug repurposing enhanced antifungal activity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334256/ https://www.ncbi.nlm.nih.gov/pubmed/29873597 http://dx.doi.org/10.2217/nnm-2017-0337 |
work_keys_str_mv | AT jarominanna topicaldeliveryofebselenencapsulatedinbiopolymericnanocapsulesdrugrepurposingenhancedantifungalactivity AT zarnowskirobert topicaldeliveryofebselenencapsulatedinbiopolymericnanocapsulesdrugrepurposingenhancedantifungalactivity AT pietkaottlikmagdalena topicaldeliveryofebselenencapsulatedinbiopolymericnanocapsulesdrugrepurposingenhancedantifungalactivity AT andesdavidr topicaldeliveryofebselenencapsulatedinbiopolymericnanocapsulesdrugrepurposingenhancedantifungalactivity AT gubernatorjerzy topicaldeliveryofebselenencapsulatedinbiopolymericnanocapsulesdrugrepurposingenhancedantifungalactivity |